1. Home
  2. ALGS vs SNAL Comparison

ALGS vs SNAL Comparison

Compare ALGS & SNAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALGS
  • SNAL
  • Stock Information
  • Founded
  • ALGS 2018
  • SNAL 2000
  • Country
  • ALGS United States
  • SNAL United States
  • Employees
  • ALGS N/A
  • SNAL N/A
  • Industry
  • ALGS Biotechnology: Pharmaceutical Preparations
  • SNAL Computer Software: Prepackaged Software
  • Sector
  • ALGS Health Care
  • SNAL Technology
  • Exchange
  • ALGS Nasdaq
  • SNAL Nasdaq
  • Market Cap
  • ALGS 53.0M
  • SNAL 51.0M
  • IPO Year
  • ALGS 2020
  • SNAL 2022
  • Fundamental
  • Price
  • ALGS $11.34
  • SNAL $0.85
  • Analyst Decision
  • ALGS Strong Buy
  • SNAL
  • Analyst Count
  • ALGS 2
  • SNAL 0
  • Target Price
  • ALGS $60.00
  • SNAL N/A
  • AVG Volume (30 Days)
  • ALGS 74.9K
  • SNAL 108.2K
  • Earning Date
  • ALGS 11-05-2025
  • SNAL 08-19-2025
  • Dividend Yield
  • ALGS N/A
  • SNAL N/A
  • EPS Growth
  • ALGS N/A
  • SNAL N/A
  • EPS
  • ALGS N/A
  • SNAL N/A
  • Revenue
  • ALGS $3,174,000.00
  • SNAL $91,041,290.00
  • Revenue This Year
  • ALGS N/A
  • SNAL $24.50
  • Revenue Next Year
  • ALGS $28.79
  • SNAL $15.42
  • P/E Ratio
  • ALGS N/A
  • SNAL N/A
  • Revenue Growth
  • ALGS N/A
  • SNAL 24.25
  • 52 Week Low
  • ALGS $3.76
  • SNAL $0.64
  • 52 Week High
  • ALGS $46.80
  • SNAL $3.42
  • Technical
  • Relative Strength Index (RSI)
  • ALGS 70.84
  • SNAL 34.11
  • Support Level
  • ALGS $10.01
  • SNAL $0.81
  • Resistance Level
  • ALGS $10.86
  • SNAL $0.97
  • Average True Range (ATR)
  • ALGS 0.97
  • SNAL 0.08
  • MACD
  • ALGS 0.13
  • SNAL 0.00
  • Stochastic Oscillator
  • ALGS 90.81
  • SNAL 9.56

About ALGS Aligos Therapeutics Inc.

Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.

About SNAL Snail Inc.

Snail Inc is an independent developer and publisher of interactive digital entertainment for consumers around the world, with a portfolio of premium games designed for use on a variety of platforms, including consoles, PC's, and mobile devices. The geographic presence of the company is in the United States and the International market, where the majority of its revenue comes from the United States.

Share on Social Networks: